Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Drugs may not be best weapon against teen migraines, study finds

18.06.2002


A new study of migraine headaches suggests behavioral therapy "not medication -- may be the most effective weapon against migraine pain for teen-agers.



Researchers with the Ohio University Headache Treatment & Research Project enrolled 30 teens ages 12 to 17 in the pilot project. Half were treated with triptans -- a fairly new class of drugs widely used for migraine in adults -- and half were assigned to a phone-administered behavioral therapy program that included instruction in biofeedback and a variety of relaxation exercises.

Eighty percent of the kids receiving behavioral therapy recorded a decrease of more than half in the number of migraines per month, according to project manager Connie Cottrell, who will present the findings at the American Headache Society annual meeting June 21 in Seattle. Teens in this group also recorded an 80 percent reduction in the hours of activities missed due to migraine pain.


These preliminary results have prompted the researchers to begin plans for a larger study of the treatment of migraines in teens. The planned project will be modeled after a National Institutes of Health-sponsored adult migraine study currently under way at the university’s headache clinics in Athens and Columbus.

Migraines are a debilitating health problem that affect some 8 million children and adolescents, resulting in more than 1 million lost school days each year, according to the JAMA Migraine Information Center. At the beginning of the study, participants in this pilot project, who kept daily diaries about their headaches, recorded an average of 3.3 migraines a month with moderate to severe pain. The teens also recorded an average of 5.1 hours per month when their headaches prevented them from participating in a variety of activities.

"Some of these kids were in so much pain, they were just tearful," Cottrell said. "There was one boy whose parent told me would just lie on the bed, hold his head and cry because the pain was so bad."

Studies over the years have revealed a lot of information about the prevention, onset and treatment of migraines in adults. But even though the peak onset for migraine headaches is around 15 years of age, there is less research on migraines in children and teens.

"The triptan therapies have proven very helpful for adults, but it has not been determined if they will be as effective for treating migraines in teens," said Ken Holroyd, a professor of health psychology at Ohio University who started the Headache Treatment and Research Project in 1975. "Triptans are promising treatments for teens. However, if teens can learn to control migraines without medication, this could save decades of medication consumption."

More than 60 kids called to participate in this pilot study, but only 30 who fit the criteria -- two to eight headaches a month that lasted at least four hours each -- were able to commit to the 16-week project.

During the first four-weeks of the study, all 30 participants kept a daily diary of their headache pain, recording the frequency and severity of their migraines. The teens also were seen by the headache project?s neurologist, Dr. Frank O?Donnell.

Participants were then randomly assigned to one of two eight-week treatment groups. Those in the drug therapy group were prescribed triptans, a class of drugs widely used for migraine in adults. The researchers called teens in this group once every two weeks to monitor the effects of the drug.

Those in the behavioral therapy group were given a manual written by Cottrell called "STOP" (Strategies to Take Out the Pain), which included information on ways to identify early signs of migraine and how to manage the triggers that bring on the pain. The book also offered training in relaxation, biofeedback and stress management. Teens read a chapter each week and discussed what they learned during a 20- to 30-minute phone conversation with project leaders.

This contact likely was key to the success of the behavioral therapy, said Cottrell, who noted that although stereotypes sometimes suggest teens have little to say to adults, teens in this study were eager to talk about their migraines.

"Most people who have headaches want to talk about them because they’re used to no one listening to them," she said. "I didn’t have any problems getting them to talk about their headaches. Some of the teen-agers didn?t do all the reading they were supposed to and in those cases, we talked about what they should have read over the phone so they were exposed to the information."

But for the most part, teens in the study were eager to learn to control their headaches, Cottrell said. The teens also responded favorably to biofeedback therapy, which, in this project, involved a small electronic thermometer that attached to a teen’s finger to measure body temperature. Kids were taught how to increase the temperature in their fingers, a process that triggers blood vessels in the head to relax, lessening headache pain.

"Interestingly enough, it was a lot easier for the teen-agers to do the biofeedback than for adults," Cottrell said. "Maybe it was because it uses a computer and kids thought it was cool or maybe kids are more open-minded."

Kids’ response to biofeedback is one of several things Cottrell hopes a larger study of migraines in teens will help her understand. She also wants to devise a plan that would help parents become more involved in the treatment of their kids’ migraines and to design an instructional tool that would do a better job of keeping teens’ attention.

"There has to be a way to get more parental involvement and support for the teen and a more enticing and attractive way to get the message to the teen-agers," Cottrell said. "Reading it in a book is too old-fashioned for young people."


###
For more information about the NIH adult migraine study, call (740) 593-1060 in Athens or (614) 839-3254 in Columbus.

Kelli Whitlock | EurekAlert!

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>